General Surgery Center, Chengdu Military General Hospital, Chengdu, Sichuan Province, China.
Department of Gastroenterology and Hepatology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan Province, China.
J Gastroenterol Hepatol. 2019 May;34(5):929-936. doi: 10.1111/jgh.14468. Epub 2018 Oct 3.
This study aims to assess the clinical validity and safety of single-operator cholangioscopy system (SOCS) for the treatment of concomitant gallbladder stones and secondary common bile duct (CBD) stones.
This retrospective study included 10 consecutive patients who had small-sized stones (< 1 cm) in both the gallbladder and CBD; the patients underwent SOCS treatment from June 2016 to December 2016. The clinical validity of this minimally invasive surgery was determined by the operation success rate, stone removal rate, postoperative hospital stay, hospitalization cost, and contrast images before and after the operation. The clinical safety was evaluated by perioperative complications and outcomes, gallbladder stone recurrence, and gallbladder contractility function.
Both the technique success rate and the stone removal rate when using SOCS was 100%. There were no serious complications that occurred during the operation; three patients developed acute cholecystitis, and four patients underwent hyperamylasemia after the surgery. The average postoperative hospital stay was 5.8 ± 1.32 days, and the average hospitalization cost was 7466 ± 566.1 dollars. In the follow-up period, which ranged from 3 to 8 months, there was no stone residuals or recurrences in the gallbladder and CBD, and no patient showed a recurrence of biliary colic. In addition, the gallbladder contractility function was proven to be normal within 3 to 6 months after the operation.
SOCS could successfully manage concomitant gallbladder stones and secondary CBD stones and precisely protect normal biliary function.
本研究旨在评估单操作胆管镜系统（SOCS）治疗并存胆囊结石和继发性胆总管（CBD）结石的临床有效性和安全性。
本回顾性研究纳入了 2016 年 6 月至 2016 年 12 月期间接受 SOCS 治疗的 10 例同时存在胆囊和 CBD 小结石（<1cm）的连续患者。该微创手术的临床有效性通过手术成功率、结石清除率、术后住院时间、住院费用以及手术前后的对比图像来确定。临床安全性通过围手术期并发症和结果、胆囊结石复发和胆囊收缩功能来评估。
SOCS 的技术成功率和结石清除率均为 100%。手术过程中没有发生严重并发症；3 例患者发生急性胆囊炎，4 例患者术后出现高淀粉酶血症。术后平均住院时间为 5.8±1.32 天，平均住院费用为 7466±566.1 美元。在 3 至 8 个月的随访期间，胆囊和 CBD 均无结石残留或复发，且无患者出现胆绞痛复发。此外，术后 3 至 6 个月证实胆囊收缩功能正常。
SOCS 可成功治疗并存胆囊结石和继发性 CBD 结石，并能精确保护正常的胆道功能。
